The ERK and p38MAPK Pathways as Targets for Anti-Inflammatory Therapy

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 6, Iss. 1, 2007-01 ,pp. : 85-97

Bentham Science Publishers

Access to resources Recommend Favorite

Exposure of C6 glioma cells to Pb(II) increases the phosphorylation of p38^MAPK and JNK1/2 but not of ERK1/2

By Posser Thaís   Aguiar Cláudia   Garcez Ricardo   Rossi Francesco   Oliveira Camila   Trentin Andréa   Moura Neto Vivaldo   Leal Rodrigo  

Archives of Toxicology, Vol. 81, Iss. 6, 2007-06 ,pp. : 407-414

Springer Publishing Company

Access to resources Recommend Favorite

Hyperglycemia Regulates TXNIP/TRX/ROS Axis via p38 MAPK and ERK Pathways in Pancreatic Cancer

By  

Current Cancer Drug Targets, Vol. 14, Iss. 4, 2014-05 ,pp. : 348-356

Bentham Science Publishers

Access to resources Recommend Favorite

Alteplase potentiates NMDA-induced neurotoxicity

By  

Inpharma, Vol. 1, Iss. 1273, 2001-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Angiotensin-(1–7) Inhibits Vascular Remodelling in Rat Jugular Vein Grafts via Reduced ERK1/2 and p38 MAPK Activity

By Wu J-G   Tang H   Liu Z-J   Ma Z-F   Tang A-L   Zhang X-J   Gao X-R   Ma H  

The Journal of International Medical Research, Vol. 39, Iss. 6, 2011-11 ,pp. : 2158-2168

Field House Publishing

Access to resources Recommend Favorite